Article Per Year (5 Year)
p-Index From 2021 - 2026
0.23
P-Index
This Author published in this journals
All Journal Edubiotik : Jurnal Pendidikan, Biologi dan Terapan
Indrajani, Olly
Unknown Affiliation
Agriculture, Biological Sciences & Forestry Biochemistry, Genetics & Molecular Biology Computer Science & IT Decision Sciences, Operations Research & Management Economics, Econometrics & Finance

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

 1 
Oxyhydrogen nanobubbles modulate β-catenin and CD8⁺ in a rat model of hepatocarcinoma Zahrah, Natasya Adiba; Agustin, Netti Astriana; Satyawati, Rendhita Ardilla Putri; Wuragil, Dyah Kinasih; Riawan, Wibi; Indrajani, Olly; Lubab, Ahmad; Hernowo, Aditya Tri; Sumitro, Sutiman Bambang; Widyarti, Sri; Aulanni'am, Aulanni'am
Edubiotik : Jurnal Pendidikan, Biologi dan Terapan Vol. 11 No. 02 (2026): November
Publisher : Biology Education Department, Universitas Insan Budi Utomo, Malang, Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.33503/ebio.v11i02.3439

Abstract

Hepatocellular carcinoma (HCC) continues to be a significant contributor to cancer-associated fatalities, highlighting the worldwide necessity for efficacious treatment approaches. This research assessed the impact of oxyhydrogen nanobubbles (HHOnbs) on β-catenin expression and CD8⁺ T-cell infiltration in a rat model of HCC caused by diethylnitrosamine (DEN) and carbon tetrachloride (CCl₄), while also contrasting their dose-dependent effects with Lenvatinib. Male Wistar rats were divided into six categories: negative control, positive control, HHOnbs given 12 or 24 times, and Lenvatinib provided 3 or 5 times. We evaluated β-catenin expression and the infiltration of CD8⁺ T-cells by immunohistochemical methods. HCC induction elevated β-catenin expression and augmented CD8⁺ T-cell infiltration. HHOnb treatment dose-dependently reduced β-catenin expression by 59.98% and 89.87% and increased CD8⁺ T-cell infiltration by 49.23% and 129.23% following 12 and 24 administrations, respectively. HHOnbs showed stronger β-catenin suppression, whereas Lenvatinib elicited greater CD8⁺ T-cell infiltration. These findings indicate that HHOnbs can suppress oncogenic signaling and enhance antitumor immune responses in experimental HCC. Future studies should assess their long-term efficacy and safety profiles and investigate combination therapies, as the present study did not evaluate these parameters.
Co-Authors Agustin, Netti Astriana Ahmad Lubab, Ahmad Aulanni'am, Aulanni'am Hernowo, Aditya Tri Satyawati, Rendhita Ardilla Putri Sri Widyarti Sutiman B. Sumitro Wibi Riawan Wuragil, Dyah Kinasih Zahrah, Natasya Adiba